Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Colorectal Neoplasms 3Brain Neoplasms 3Pancreatic Neoplasms 2Breast Neoplasms 2Warts 1Surgical Wound 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Diseases 1Sarcoma 1Radiodermatitis 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neuroinflammatory Diseases 1Melanoma 1Lung Neoplasms 1Locally Advanced Cervical Cancer 1Limited Stage Small Cell Lung Cancer 1Hypoxia 1Hemorrhage 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Atrial Fibrillation 1

Interventions

Cyclophosphamide 15fludarabine 12Mycophenolic Acid 10Standard of Care 9Whole-Body Irradiation 7Tacrolimus 7venetoclax 6Specimen Handling 6Sirolimus 6Practice Guidelines as Topic 6trametinib 5Melphalan 5fludarabine phosphate 4Mesna 4Magnetic Resonance Spectroscopy 4Filgrastim 4Biopsy 4Behavior Therapy 4Azacitidine 4Thiotepa 3Peripheral Blood Stem Cell Transplantation 3GSK2636771 3Educational Status 3Crizotinib 3Busulfan 3thymoglobulin 2talquetamab 2ruxolitinib 2palbociclib 2osimertinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Sodium Chloride × 90 days × Clear all
NCT05952804 2026-04-21

IVIG for Infection Prevention After CAR-T-Cell Therapy

Fred Hutchinson Cancer Center

Phase 2 Recruiting
150 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡